SMD Rise PCL's EBIT per Share for the
three
months ended in Mar. 2026 was ฿-0.13.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ฿0.16.
During the past 12 months, the average EBIT per Share Growth Rate of SMD Rise PCL was -36.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -52.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -31.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for SMD Rise PCL's EBIT per Share or its related term are showing as below:
BKK:SMD100-R'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -52.4 Med: -29 Max: 64
Current: -52.4
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of SMD Rise PCL was 64.00% per year. The lowest was -52.40% per year. And the median was -29.00% per year.
BKK:SMD100-R's 3-Year EBIT Growth Rate is ranked worse than 93.4% of 106
companies
in the Medical Distribution industry
Industry Median: 4.1
vs BKK:SMD100-R: -52.40
SMD Rise PCL's EBIT for the
three
months ended in Mar. 2026 was ฿-26.9 Mil.
SMD Rise PCL (BKK:SMD100-R) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
SMD Rise PCL EBIT per Share Related Terms
SMD Rise PCL EBIT per Share Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.16
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMD Rise PCL (BKK:SMD100-R) has a EBIT per Share of ฿0.16 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on SMD Rise PCL and its competitors. According to the industry distribution chart, SMD Rise PCL ranks #99 out of 106 companies in the Medical Distribution industry, placing it in the top 93.4%.
Is SMD Rise PCL's EBIT per Share too high?
SMD Rise PCL's current EBIT per Share is ฿0.16. Based on the distribution chart, SMD Rise PCL ranks #99 out of 106 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's EBIT per Share compare to MCK and COR?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #99 out of 106 companies for EBIT per Share. This places SMD Rise PCL in the lower half of its industry. The industry median EBIT per Share is 4.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.10, based on 106 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current EBIT per Share is ฿0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current EBIT per Share of ฿0.16. The stock's GF Value™ is ฿24.66, compared to a current price of ฿5.85 — trading 76.3% below its estimated fair value. The current EBIT per Share is ฿0.16. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current EBIT per Share is ฿0.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 76.3% below its estimated GF Value™ of ฿24.66.
Key valuation signals for BKK:SMD100-R:
EBIT per Share: ฿0.16
GF Value™: ฿24.66 vs. price of ฿5.85 (76.3% below fair value)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
